TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Patrick Gaynes
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock

Pasithea Therapeutics raised $60 million through a public offering of 80 million shares at $0.75 per share, led by healthcare investors. The proceeds will support ongoing research and extend the company's cash runway through the first half of 2028.

Insights
LITE   neutral

Briefly mentioned in related articles, no specific performance details provided


KTTA   positive

Successfully raised significant capital, extended cash runway, and continuing clinical trials for PAS-004 in multiple indications